Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 3
2001 1
2002 3
2003 3
2004 11
2005 7
2006 9
2007 6
2008 14
2009 11
2010 6
2011 13
2012 15
2013 11
2014 11
2015 7
2016 8
2017 15
2018 19
2019 16
2020 22
2021 29
2022 23
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Endothelial dysfunction and immunothrombosis in sepsis.
Maneta E, Aivalioti E, Tual-Chalot S, Emini Veseli B, Gatsiou A, Stamatelopoulos K, Stellos K. Maneta E, et al. Among authors: stamatelopoulos k. Front Immunol. 2023 Apr 4;14:1144229. doi: 10.3389/fimmu.2023.1144229. eCollection 2023. Front Immunol. 2023. PMID: 37081895 Free PMC article. Review.
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review.
Georgiopoulos G, Makris N, Laina A, Theodorakakou F, Briasoulis A, Trougakos IP, Dimopoulos MA, Kastritis E, Stamatelopoulos K. Georgiopoulos G, et al. Among authors: stamatelopoulos k. JACC CardioOncol. 2023 Feb 21;5(1):1-21. doi: 10.1016/j.jaccao.2022.12.005. eCollection 2023 Feb. JACC CardioOncol. 2023. PMID: 36875897 Free PMC article. Review.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Hart RG, et al. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766772 Free article. Clinical Trial.
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease.
Delialis D, Dimopoulou MA, Papaioannou M, Kotsira G, Maneta E, Mavraganis G, Loutos C, Georgiopoulos G, Stamatelopoulos K. Delialis D, et al. Among authors: stamatelopoulos k. Curr Pharm Des. 2023;29(23):1802-1824. doi: 10.2174/1381612829666230412105238. Curr Pharm Des. 2023. PMID: 37055909 Review.
The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation.
Gatsiou A, Tual-Chalot S, Napoli M, Ortega-Gomez A, Regen T, Badolia R, Cesarini V, Garcia-Gonzalez C, Chevre R, Ciliberti G, Silvestre-Roig C, Martini M, Hoffmann J, Hamouche R, Visker JR, Diakos N, Wietelmann A, Silvestris DA, Georgiopoulos G, Moshfegh A, Schneider A, Chen W, Guenther S, Backs J, Kwak S, Selzman CH, Stamatelopoulos K, Rose-John S, Trautwein C, Spyridopoulos I, Braun T, Waisman A, Gallo A, Drakos SG, Dimmeler S, Sperandio M, Soehnlein O, Stellos K. Gatsiou A, et al. Among authors: stamatelopoulos k. Immunity. 2023 May 9;56(5):979-997.e11. doi: 10.1016/j.immuni.2023.03.021. Epub 2023 Apr 25. Immunity. 2023. PMID: 37100060 Free article.
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.
Aimo A, Pateras K, Stamatelopoulos K, Bayes-Genis A, Lombardi CM, Passino C, Emdin M, Georgiopoulos G. Aimo A, et al. Among authors: stamatelopoulos k. Cardiovasc Drugs Ther. 2021 Oct;35(5):1067-1076. doi: 10.1007/s10557-020-07099-2. Epub 2020 Oct 19. Cardiovasc Drugs Ther. 2021. PMID: 33074526
RNA-binding proteins in vascular inflammation and atherosclerosis.
Sachse M, Tual-Chalot S, Ciliberti G, Amponsah-Offeh M, Stamatelopoulos K, Gatsiou A, Stellos K. Sachse M, et al. Among authors: stamatelopoulos k. Atherosclerosis. 2023 Jun;374:55-73. doi: 10.1016/j.atherosclerosis.2023.01.008. Epub 2023 Jan 17. Atherosclerosis. 2023. PMID: 36759270 Free article. Review.
252 results